| Literature DB >> 30670721 |
Jiajie Zhou1,2, Yi Li1, Jianfeng Gong1, Weiming Zhu3.
Abstract
The aim of this study was to investigate the impact of staging operation on the risk of reoperation in patients with CD who underwent primary bowel resection. This was a retrospective study of 980 patients with CD who were hospitalized in Jinling Hospital Affiliated to Nanjing Medical University between January 1, 2001, and October 1, 2016. The patients were grouped according to staging operation (n = 64) and one-stage operation (n = 148). Postoperative intestinal function recovery time, postoperative short-term complications, and reoperation rates were compared between the two groups. There was significant difference in disease behavior between the staging operation group and the one-stage operation group. There was no significant difference in postoperative tolerance of enteral nutrition among groups (P > 0.05). Obvious differences were found in the comparison of the first time of exhaustion, defecation after operation, postoperative length of stay and postoperative complications among groups (all P < 0.05). There was no difference in the 5-year cumulative reoperation-free rates between the two groups (P > 0.05). In conclusion, surgical intervention at proper time and appropriate operation during operation are essential for patients with CD. It is believed that staging operation with ostomy followed by intestinal anastomosis is feasible when there are more than two risk factors for postoperative intra-abdominal infectious complications.Entities:
Mesh:
Year: 2019 PMID: 30670721 PMCID: PMC6342980 DOI: 10.1038/s41598-018-34867-w
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Study selection flow chart.
Characteristics of the Patients.
| Variables | Group 1 (n = 148) | Group 2 (n = 64) first stage | P |
|---|---|---|---|
| Female | 91 (61.5%) | 49 (76.6%) | 0.591 |
| Duration of disease (months) | 35 (1–226) | 33 (1–243) | 0.579 |
|
| |||
| Abdominal abscess drainage | 35 (23.6%) | 10 (61.5%) | 0.190 |
| Appendectomy | 28 (18.9%) | 12 (15.6%) | 0.977 |
| Perianal operation | 26 (17.6%) | 14 (21.9%) | 0.462 |
| Smoking history | 9 (6.1%) | 5 (7.8%) | 0.641 |
|
| |||
| Laparoscopic/open | 58/90 | 8/56 | <0.001 |
|
| |||
| emergency/selective | 1/147 | 9/55 | <0.001 |
|
| |||
| Age of diagnosis | 0.713 | ||
| A1 (≤16 years) | 11 (7.4%) | 8 (12.5%) | |
| A2 (17–40 years) | 107 (72.3%) | 42 (65.6%) | |
| A3 (>40 years) | 30 (20.3%) | 14 (21.9%) | |
| Location of disease | 0 0.363 | ||
| L1 (Terminal ileum) | 69 (46.6%) | 26 (40.6%) | |
| L2 (Colonic) | 9 (6.1%) | 13 (20.3%) | |
| L3 (Ileocolonic) | 44 (29.7%) | 24 (37.5%) | |
| L4 (Upper GI) | 26 (17.6%) | 1 (1.6%) | |
| Behavior of disease | <0.001 | ||
| B1 (Non-str/non-pen) | 8 (5.4%) | 5 (7.8%) | |
| B2 (Stricturing) | 85 (57.4%) | 16 (25%) | |
| B3 (Penetrating) | 55 (33.5%) | 43 (67.1%) | |
| P (Perianal lesions) | 34 (29.8%) | 20 (31.2%) | 0.204 |
| Postoperative management | 0.253 | ||
| Mesalazine | 13 (8.8) | 2 (3.1%) | |
| Azathioprine | 115 (77.7%) | 48 (75%) | |
| Remicade | 2 (1.4%) | 2 (3.1%) | |
| Tripterygium glycosides | 17 (11.5%) | 10 (15.6%) | |
| Thalidomide | 1 (0.7%) | 2 (3.1%) | |
GI: gastointestinal; non-str: non-stricturing; non-pen: non-penetrating.
Group A: one-stage operation group; Group B: staging operation group.
Postoperative observation indexes.
| Postoperative observation indexes | Group1 (n=148) | Group 2 (n=64) | Group 2 (n=64) | P |
|---|---|---|---|---|
| first stage | second stage | |||
| Time of exhaustion (days) | 3 (1–8) | 2 (1–13) | 3 (2–7) | <0.001 |
| Time of defecation (days) | 3 (1–9) | 2 (1–13) | 3 (2–7) | <0.001 |
| Tolerance period of enteral nutrition (days) | 4 (2–20) | 4 (1–15) | 4 (2–10) | 0.653 |
| Postoperative hospital stay (days) | 6 (3–33) | 9 (3–56) | 7.5 (3–25) | 0.021 |
|
| 0.013 | |||
|
| 20 (13.5%) | 6 (9.3%) | 12 (18.8%) | |
| Abdominal distension | 4 (2.7%) | 2 (3.1%) | 2 (3.1%) | |
| Infection of incisional wound | 8 (5.4%) | 4 (6.3%) | 9 (14.1%) | |
| Diarrhea | 7 (4.7%) | |||
| Hydrothorax | 1 (0.7%) | 1 (1.7%) | ||
|
| 28 (18.9%) | 24 (37.5%) | 18 (28.1%) | |
| Intestinal obstruction | 1 (0.7%) | 1 (1.6%) | ||
| Incision bleeding | 1 (0.7%) | 1 (1.6%) | ||
| Fungal infection | 1 (1.6%) | |||
| Abdominal distension | 12 (8.1%) | 4 (6.3%) | 11 (17.2%) | |
| High-output stoma | 7 (10.9%) | |||
| Anemia | 6 (4.1%) | 10 (15.6%) | 1 (1.6%) | |
| Anastomotic bleeding | 1 (0.7%) | 1 (1.6%) | ||
| Diarrhea | 5 (3.4%) | 5 (7.8%) | ||
| Intra-abdominal infection | 1 (0.7%) | |||
| Pulmonary infection | 1 (0.7%) | |||
|
| 9 (6.1%) | 7 (10.9%) | 4 (6.3%) | |
| Duodenal fistula | 1 (1.6%) | |||
| Cholecystitis | 1 (1.6%) | |||
| Pleural effusion | 3 (4.7%) | 1 (1.6%) | ||
| Hydrops abdominis | 2 (1.4%) | 2 (3.1%) | ||
| Anastomotic fistula | 4 (2.7%) | 1 (1.6%) | ||
| Intra-abdominal hemorrhage | 1 (0.7%) | |||
| Incision hemorrhage | 1 (0.7%) | 1 (1.6%) | ||
| Intra-abdominal abscess | 1 (0.7%) | 1 (1.6%) | ||
|
| 5 (7.8%) | |||
| Infectious shock | 3 (4.7%) | |||
| Anastomotic hemorrhage | 1 (1.6%) | |||
| Cardiac failure | 1 (1.6%) |